Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

Next Previous
Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ibrexafungerp (Primary) ; Fluconazole
  • Indications Vulvovaginal candidiasis
  • Focus Therapeutic Use
  • Acronyms DOVE
  • Sponsors SCYNEXIS

    • Most Recent Events

    • 12 Nov 2019 According to a SCYNEXIS media release, results of post hoc analysis from the study were presented at 3rd International Society of Infectious Diseases in Obstetrics and Gynecology (ISIDOG).
    • 31 Oct 2019 Results presented in a SCYNEXIS Media Release.
    • 31 Oct 2019 According to a SCYNEXIS media release, data from a post-hoc analysis of this study will be presented at the 3rd International Society of Infectious Diseases in Obstetrics and Gynecology (ISIDOG) Congress occurring October 31- November 2, 2019 in Porto, Portugal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top